NEUROENDOCRINE TUMOR OF PANCREAS
Clinical trials for NEUROENDOCRINE TUMOR OF PANCREAS explained in plain language.
Never miss a new study
Get alerted when new NEUROENDOCRINE TUMOR OF PANCREAS trials appear
Sign up with your email to follow new studies for NEUROENDOCRINE TUMOR OF PANCREAS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
First human trial launches for targeted radiation therapy against Hard-to-Treat neuroendocrine tumors
Disease control OngoingThis early-phase study tests a new radioactive drug, [212Pb] VMT-α-NET, in 24 adults with advanced neuroendocrine tumors that have not responded to other treatments. The main goal is to find a safe dose for future studies, not to treat the disease. Participants receive up to two …
Matched conditions: NEUROENDOCRINE TUMOR OF PANCREAS
Phase: EARLY_PHASE1 • Sponsor: David Bushnell • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
New hope for rare pancreatic cancer: experimental drug enters trial
Disease control ENROLLING_BY_INVITATIONThis study tests a drug called lurbinectedin in people with high-grade pancreatic neuroendocrine tumors (a rare, fast-growing cancer) who have already tried standard treatments. The goal is to see if the drug can shrink tumors or stop them from growing. About 46 adults will take …
Matched conditions: NEUROENDOCRINE TUMOR OF PANCREAS
Phase: PHASE2 • Sponsor: National Cancer Center, Korea • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC